There is an increased scrutiny on clinical contractor pharmacies.
Our previous newsletters detail sterile compounding and the more rigorous compliance evaluation with USP Chapter 797.
Again this month in the “Consistent Interpretation” column, details the leadership contracting standards with clinical contractor pharmacies. Yet again, it requires hospitals to evaluate clinical contractor pharmacies. And, raises the bar for hospital oversight of these contractors.
Perspectives details yet another update on corridor door requirements and eliminating roller latches.
The CMS first focused on eliminating roller latches in 2003. But, as a result of CMS and NFPA modifications, the Joint Commission changed LS.02.01.30, EP 13 as of March 11, 2018.
The change to the EP appears to be “wordsmithing.” But, since some authorities might question that “wordsmithing” is actually a word, let’s call it fine tuning!
For organizations performing fluoroscopy services, there are new requirements effective July 1, 2018.
We don’t believe you will find the requirements challenging. But, since the article combines changes to the ambulatory care, critical access hospital, hospital and office based surgery accreditation programs, it is a bit confusing.